We are pleased to announce the successful development of our first plant clonal expression system. This groundbreaking system paves the way for the development of specific expression chassis for use in both the pharmaceutical and biotechnology industries.

Our newly developed protocol allows for high comparability, which is essential for the development of efficient and reliable expression chassis. With this system, we can now offer tailor-made solutions for a wide range of applications.

This breakthrough is the result of years of research and development and represents a significant milestone in our quest to push the boundaries of plant biotechnology. We are proud to have achieved this goal and look forward to the exciting opportunities that lie ahead.

Our team has worked tirelessly to develop and optimise this system. Their dedication and expertise have enabled us to achieve this ambitious goal. We would like to thank them for their commitment and passion.

With this success, we are well positioned to continue delivering innovative solutions to the pharmaceutical and biotechnology industries. We look forward to seeing the fruits of our labour and are excited about the next steps in our journey. With our new clonal expression system, we are ready to take on tomorrow’s challenges and remain at the forefront of biotechnology innovation.